PortfoliosLab logoPortfoliosLab logo
NVOH vs. IPOS
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

NVOH vs. IPOS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Renaissance International IPO ETF (IPOS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NVOH vs. IPOS - Yearly Performance Comparison


Returns By Period

In the year-to-date period, NVOH achieves a -24.75% return, which is significantly lower than IPOS's 11.50% return.


NVOH

1D
-1.00%
1M
0.42%
YTD
-24.75%
6M
-34.28%
1Y
-46.24%
3Y*
5Y*
10Y*

IPOS

1D
3.33%
1M
-9.87%
YTD
11.50%
6M
8.27%
1Y
48.78%
3Y*
5.45%
5Y*
-11.43%
10Y*
0.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NVOH vs. IPOS - Expense Ratio Comparison

NVOH has a 0.19% expense ratio, which is lower than IPOS's 0.80% expense ratio.


Return for Risk

NVOH vs. IPOS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVOH
NVOH Risk / Return Rank: 11
Overall Rank
NVOH Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NVOH Sortino Ratio Rank: 11
Sortino Ratio Rank
NVOH Omega Ratio Rank: 11
Omega Ratio Rank
NVOH Calmar Ratio Rank: 11
Calmar Ratio Rank
NVOH Martin Ratio Rank: 11
Martin Ratio Rank

IPOS
IPOS Risk / Return Rank: 8181
Overall Rank
IPOS Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
IPOS Sortino Ratio Rank: 7979
Sortino Ratio Rank
IPOS Omega Ratio Rank: 8181
Omega Ratio Rank
IPOS Calmar Ratio Rank: 8686
Calmar Ratio Rank
IPOS Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVOH vs. IPOS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Renaissance International IPO ETF (IPOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVOHIPOSDifference

Sharpe ratio

Return per unit of total volatility

-0.88

1.68

-2.56

Sortino ratio

Return per unit of downside risk

-1.14

2.11

-3.25

Omega ratio

Gain probability vs. loss probability

0.84

1.33

-0.48

Calmar ratio

Return relative to maximum drawdown

-0.89

2.84

-3.73

Martin ratio

Return relative to average drawdown

-1.51

8.62

-10.13

NVOH vs. IPOS - Sharpe Ratio Comparison

The current NVOH Sharpe Ratio is -0.88, which is lower than the IPOS Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of NVOH and IPOS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NVOHIPOSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.88

1.68

-2.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.43

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.98

0.01

-0.99

Correlation

The correlation between NVOH and IPOS is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NVOH vs. IPOS - Dividend Comparison

NVOH's dividend yield for the trailing twelve months is around 4.56%, more than IPOS's 0.85% yield.


TTM20252024202320222021202020192018201720162015
NVOH
Novo Nordisk A/S (B Shares) ADRhedged ETF
4.56%2.38%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IPOS
Renaissance International IPO ETF
0.85%1.04%0.93%0.33%0.00%0.00%0.25%0.89%1.12%0.87%1.73%1.08%

Drawdowns

NVOH vs. IPOS - Drawdown Comparison

The maximum NVOH drawdown since its inception was -61.60%, smaller than the maximum IPOS drawdown of -73.09%. Use the drawdown chart below to compare losses from any high point for NVOH and IPOS.


Loading graphics...

Drawdown Indicators


NVOHIPOSDifference

Max Drawdown

Largest peak-to-trough decline

-61.60%

-73.09%

+11.49%

Max Drawdown (1Y)

Largest decline over 1 year

-53.00%

-17.17%

-35.83%

Max Drawdown (5Y)

Largest decline over 5 years

-70.33%

Max Drawdown (10Y)

Largest decline over 10 years

-73.09%

Current Drawdown

Current decline from peak

-60.40%

-52.62%

-7.78%

Average Drawdown

Average peak-to-trough decline

-36.02%

-31.78%

-4.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.21%

5.66%

+25.55%

Volatility

NVOH vs. IPOS - Volatility Comparison

The current volatility for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) is 8.19%, while Renaissance International IPO ETF (IPOS) has a volatility of 15.75%. This indicates that NVOH experiences smaller price fluctuations and is considered to be less risky than IPOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NVOHIPOSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.19%

15.75%

-7.56%

Volatility (6M)

Calculated over the trailing 6-month period

37.53%

24.15%

+13.38%

Volatility (1Y)

Calculated over the trailing 1-year period

52.51%

29.25%

+23.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.04%

26.52%

+24.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.04%

23.70%

+27.34%